|
AVTX Avalo Therapeutics Inc 1534120 |
| Balance Sheet |
|
Current Assets
|
$407,932,000.00 |
|
Assets
|
$490,783,000.00 |
|
Current Liabilities
|
$21,130,000.00 |
|
Liabilities
|
$42,123,000.00 |
|
Equity
|
$448,660,000.00 |
|
Shares Out
|
52900692.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-37,679,000.00 |
|
Investing Cash Flow
|
$-304,420,000.00 |
| Market Analysis |
Market Cap
|
$1,048,491,715.44 |
|
Price
|
$19.82 |
|
BVPS
|
8.48 |
|
PB
|
2.34 |
|
EPS
|
-0.83 |
|
PS
|
17771.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:27 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVTX documents filed with the SEC.
AVTX Filings
Clear
